Edition:
United States

Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

275.58USD
14 Dec 2018
Change (% chg)

$-4.87 (-1.74%)
Prev Close
$280.45
Open
$279.61
Day's High
$281.60
Day's Low
$272.01
Volume
388,479
Avg. Vol
343,463
52-wk High
$300.45
52-wk Low
$215.58

Latest Key Developments (Source: Significant Developments)

Anthem-To Reaffirm Net Income Guidance For Full Year 2018 To Be Greater Than $14.46 Per Share
Thursday, 29 Nov 2018 05:44pm EST 

Nov 29 (Reuters) - Anthem Inc ::ANTHEM INC - TO REAFFIRM NET INCOME GUIDANCE FOR FULL YEAR 2018 TO BE GREATER THAN $14.46 PER SHARE.ANTHEM INC - CONTINUES TO EXPECT ADJUSTED NET INCOME TO BE GREATER THAN $15.60 PER SHARE FOR FULL YEAR 2018.  Full Article

Anthem - Intend To Reaffirm FY Net Income Guidance
Wednesday, 12 Sep 2018 06:16am EDT 

Sept 12 (Reuters) - Anthem Inc ::ANTHEM - INTEND TO REAFFIRM THE COMPANY’S NET INCOME GUIDANCE FOR FULL YEAR 2018 TO BE GREATER THAN $14.20 PER SHARE - SEC FILING.EXCLUDING ITEMS, CONTINUES TO EXPECT FY ADJUSTED NET INCOME TO BE GREATER THAN $15.40 PER SHARE.FY2018 EARNINGS PER SHARE VIEW $15.49 -- THOMSON REUTERS I/B/E/S.  Full Article

Anthem Announces Collaboration With Walmart
Monday, 20 Aug 2018 08:00am EDT 

Aug 20 (Reuters) - Anthem Inc ::ANTHEM ANNOUNCES COLLABORATION WITH WALMART.ANTHEM - ENTERED ARRANGEMENT WITH WALMART TO PROVIDE CONSUMERS WITH INCREASED ACCESS TO OTC MEDICINES.ANTHEM - PROGRAM WILL ENABLE CONSUMERS ENROLLED IN ANTHEM'S AFFILIATED MA PLANS TO USE OTC PLAN ALLOWANCES TO PURCHASE OTC MEDICATIONS AT WALMART'S STORES AND ON WALMART.COM.ANTHEM - ANTHEM-WALMART PROGRAM WILL BE LAUNCHING IN JAN 2019.ANTHEM - PROGRAM TO ALLOW CONSUMERS ENROLLED IN CO'S AFFILIATED MA PLANS TO USE OTC PLAN ALLOWANCES TO BUY OTC MEDICATIONS, AMONG OTHERS AT WALMART.  Full Article

Third Point LLC Cuts Share Stake In Facebook By 25 Pct To 3 Mln Class A Shares
Friday, 10 Aug 2018 04:39pm EDT 

Aug 10 (Reuters) - Third Point LLC: :THIRD POINT LLC CUTS SHARE STAKE IN FACEBOOK INC BY 25 PERCENT TO 3 MILLION CLASS A SHARES.THIRD POINT LLC DISSOLVES SHARE STAKE IN ANTHEM INC.THIRD POINT LLC - CHANGE IN HOLDINGS ARE AS OF JUNE 30, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF MARCH 31, 2018 - SEC FILING.  Full Article

Anthem Will Not 'rescale" Obamacare Business But Is Pleased With 2018 Performance
Wednesday, 25 Jul 2018 09:47am EDT 

July 25 (Reuters) - Anthem Inc ::CEO EXPECTS TO INCREASE MEDICARE ADVANTAGE MARKET SHARE FOR GROUP SALES SEGMENT- CONF CALL.ANTHEM CEO BACKS PREVIOUS ESTIMATE FOR $4 BILLION IN SAVINGS RELATED TO MANAGING PHARMACY BENEFITS INTERNALLY- CONF CALL.ANTHEM CEO WILL NOT 'RESCALE" THE OBAMACARE INDIVIDUAL INSURANCE BUSINESS BUT IS PLEASED WITH 2018 PERFORMANCE- CONF CALL.  Full Article

Jana Partners LLC Takes Sole Share Stake In Allergan, Boston Scientific
Tuesday, 15 May 2018 09:45am EDT 

May 15 (Reuters) - Jana Partners LLC ::JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN ALLERGAN PLC OF 12,000 SHARES - SEC FILING.JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN AGILENT TECHNOLOGIES INC OF 1.0 MILLION SHARES.JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN ANTHEM INC OF 610,593 SHARES.JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN W W GRAINGER INC.JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN BOSTON SCIENTIFIC CORP OF 4.7 MILLION SHARES.JANA PARTNERS LLC - CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF DEC 31, 2017.  Full Article

Diplomat Pharmacy Appoints Brian Griffin As CEO And Chairman Of Board
Thursday, 10 May 2018 08:35am EDT 

May 10 (Reuters) - Diplomat Pharmacy Inc ::DIPLOMAT PHARMACY APPOINTS BRIAN GRIFFIN AS CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD.DIPLOMAT PHARMACY INC - BOARD WILL EXPAND TO EIGHT MEMBERS WITH GRIFFIN'S APPOINTMENT.  Full Article

Anthem Chief Operating Officer Deepti Jain To Lead Ingeniorx
Thursday, 10 May 2018 06:30am EDT 

May 10 (Reuters) - Anthem Inc ::CHIEF OPERATING OFFICER DEEPTI JAIN TO LEAD INGENIORX.ANTHEM INC - DEEPTI JAIN WILL LEAD INGENIORX, ANTHEM'S NEWLY LAUNCHED PHARMACY BENEFITS MANAGER.ANTHEM INC - CONDUCTING EXTERNAL SEARCH TO FILL INGENIORX CEO ROLE FOLLOWING DEPARTURE OF BRIAN GRIFFIN, WHO HAS RESIGNED FROM COMPANY.  Full Article

Anthem Q4 Earnings Per Share $4.67
Wednesday, 31 Jan 2018 06:00am EST 

Jan 31 (Reuters) - Anthem Inc ::ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS REFLECTING BALANCED PERFORMANCE ACROSS ITS BUSINESS UNITS.Q4 EARNINGS PER SHARE $4.67.Q4 REVENUE ROSE 5.8 PERCENT TO $89.1 BILLION.Q4 REVENUE VIEW $22.21 BILLION -- THOMSON REUTERS I/B/E/S.Q4 EARNINGS PER SHARE VIEW $1.27 -- THOMSON REUTERS I/B/E/S.Q4 ADJUSTED EARNINGS PER SHARE $1.29.BENEFIT EXPENSE RATIO WAS 88.6 PERCENT IN Q4 OF 2017, AN INCREASE OF 140 BASIS POINTS FROM 87.2 PERCENT IN PRIOR YEAR QUARTER.BOARD OF DIRECTORS INCREASES QUARTERLY DIVIDEND BY 7.1% TO $0.75 PER SHARE.‍EXPECTS ITS FULL YEAR 2018 NET INCOME TO BE GREATER THAN $14.28 PER SHARE​.‍ FULL YEAR 2018 ADJUSTED NET INCOME IS EXPECTED TO BE GREATER THAN $15.00 PER SHARE​.MEDICAL ENROLLMENT TOTALED ABOUT 40.2 MILLION MEMBERS AT DECEMBER 31, 2017, INCREASE OF 325,000 MEMBERS.ANTICIPATES LOCAL GROUP MEDICAL COST TREND WILL BE IN RANGE OF 6.0% +/- 50 BASIS POINTS IN 2018.ANTHEM - Q4 NET INCOME INCLUDED NET POSITIVE ADJUSTMENT ITEMS OF $3.38/SHARE OF WHICH $4.21 RELATES TO A ONE-TIME, NON-CASH DEFERRED TAX BENEFIT.ANTHEM - ‍ 2018 OUTLOOK INCLUDES NET BENEFIT FROM TAX REFORM OF ABOUT $2.00 PER SHARE AFTER ADJUSTING FOR EXPECTED PREMIUM REDUCTIONS, AMONG OTHERS​.‍ FULL YEAR 2018 MEDICAL MEMBERSHIP IS EXPECTED TO BE IN RANGE OF 40,000,000 - 40,200,000​.2018 OPERATING REVENUE IS EXPECTED TO BE IN RANGE OF $90.5 - $91.5 BILLION.2018 OPERATING CASH FLOW IS EXPECTED TO BE GREATER THAN $4.0 BILLION.  Full Article

Anthem Inc - Board Increased Company's Share Repurchase Authorization By $5 Billion
Thursday, 7 Dec 2017 04:44pm EST 

Dec 7 (Reuters) - Anthem Inc ::ANTHEM INC - ON DECEMBER 7, 2017, BOARD INCREASED COMPANY'S SHARE REPURCHASE AUTHORIZATION BY $5 BILLION.ANTHEM INC - ALONG WITH NEW BUYBACK PROGRAM, CURRENT TOTAL AMOUNT AVAILABLE FOR SHARE REPURCHASES IS ABOUT $7.3 BILLION.  Full Article

Photo

Anthem predicts better 2019 than Wall Street forecast, shares rise

Anthem Inc on Wednesday said its own expectations for 2019 earnings are ahead of current Wall Street estimates and the health insurer also raised its 2018 profit forecast, and its shares rose as much as 5 percent.